Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Leukemia|August 27, 2010
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapiesM A Dimopoulos, E Kastritis, D Christoulas, et al.
Cell Death Discovery|November 24, 2021
Receptor interacting protein 3 kinase, not 1 kinase, through MLKL-mediated necroptosis is involved in UVA-induced corneal endothelium cell deathZhen Yu, Nikolaos E Efstathiou, Victor S M C Correa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapyA Bamias, E Efstathiou, L A Moulopoulos, et al.
Cell Death Discovery|December 12, 2022
UVA induces retinal photoreceptor cell death via receptor interacting protein 3 kinase mediated necroptosisZhen Yu, Victor S M C Correa, Nikolaos E Efstathiou, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2019
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patientsH J Boyle, S Alibhai, L Decoster, et al.
Anticancer Research|August 5, 2006
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome dataD Mauri, G Pentheroudakis, D Bafaloukos, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 4, 2015
Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathiesE Goussetis, E Efstathiou, A Paisiou, et al.
Plos One|December 28, 2020
Acadesine suppresses TNF-α induced complement component 3 (C3), in retinal pigment epithelial (RPE) cellsNikolaos E Efstathiou, Giannis A Moustafa, Daniel E Maidana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology GroupN Xiros, P Papacostas, T Economopoulos, et al.
Bone Marrow Transplantation|November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trialC Papadimitriou, U Dafni, A Anagnostopoulos, et al.
Pageof 8